Health
YouTube will remove cancer treatment misinformation
Silhouettes of laptop and mobile device users are seen next to a screen projection of the YouTube logo. Dado Ruvic | Reuters YouTube on Tuesday announced a new policy for combatting medical misinformation on the video-sharing platform, according to a blog post. The company said it will streamline its existing guidelines to fall under three […]
Read More
As the new Eris Covid variant spreads across the world, here’s what we know so far
An illustrative image of a person holding a medical syringe and a vaccine vial in front of the Pfizer logo displayed on a screen. Nurphoto | Nurphoto | Getty Images The World Health Organization is monitoring a new strain of Covid-19 called EG.5, or “Eris,” that accounts for a growing share of cases in countries […]
Read More
Earth just had its hottest July ‘by a long shot,’ NASA and NOAA say
The planet had its warmest July on record “by a long shot” — and very likely also had its warmest-ever month in 174 years of record-keeping — according to NASA and the National Oceanic and Atmospheric Administration. The striking data, presented Monday by scientists from both agencies, indicate that last month smashed Earth’s previous July record […]
Read More
UBS says this stock is the ‘best story’ among U.S. large caps, sees more than 15% upside ahead
Eli Lilly has had a great run, but UBS expects about 16% further upside in the coming months as a steady stream of positive news propels the stock higher and revenue growth accelerates. Calling it the “best fundamental story” among U.S. large caps, UBS analyst Colin Bristow on Friday lifted his price target to $612 […]
Read More
Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about 5.5% to start the week. Morgan Stanley reiterated Nvidia […]
Read More
SEC investigating Illumina over acquisition of cancer test developer Grail
A building on the campus at the world headquarters of Illumina is shown in San Diego, California, September 1, 2021. Mike Blake | Reuters The Securities and Exchange Commission is investigating Illumina over its controversial $7.1 billion acquisition of cancer test developer Grail, the DNA sequencing company said in a securities filing late Thursday. Last […]
Read More
Hawaii wildfires: Biden vows immediate aid, deploys military to assist victims
An aerial view of a wildfire in Kihei, Maui County, Hawaii, U.S., August 8, 2023 in this screen grab obtained from a social media video. Clint Hansen Of Maui Real Estate | Via Reuters President Joe Biden on Thursday vowed immediate assistance for Maui residents who have lost loved ones and their homes in devastating […]
Read More
These 10 medications are likely targets for Medicare price negotiations this fall
Merck & Co. Inc. Januvia brand medication, used to treat type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in the program’s nearly six-decade history. The Centers for Medicare […]
Read More
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire Inversago Pharma, a privately held obesity drug maker, for up to $1.08 billion to broaden the Danish company’s blockbuster weight loss portfolio. The deal is Novo Nordisk’s latest attempt to capitalize on the weight loss industry gold rush, which began […]
Read More
Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring sales. The Danish pharmaceutical company reported a 30% increase […]
Read More